Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Which patients with hypertrophic cardiomyopathy should receive a cardioverter defibrillator? (CROSBI ID 141430)

Prilog u časopisu | stručni rad

Petrač, Dubravko Which patients with hypertrophic cardiomyopathy should receive a cardioverter defibrillator? // Acta clinica Croatica, 44 (2005), 4; 389-394

Podaci o odgovornosti

Petrač, Dubravko

engleski

Which patients with hypertrophic cardiomyopathy should receive a cardioverter defibrillator?

Ventricular tachyarrhythmias are the most common cause of sudden cardiac detah in hypertrophic cardiomyopathy. ICD is strongly warranted for secondary prevention of sudden death in patients who have survived cardiac arrest or spontanous sustained ventricular tachycardia. Because the presence of two or more risk factors confers an annual mortality rat of sudden death of 3%-&% or more, their presence in patients with hypertrophic cardiomyopathy justifes prophylactic therapy with ICD for primary prevention of sudden death.

cardiomyopathy-therapy; defibrillators-implantable; risk factors

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

44 (4)

2005.

389-394

objavljeno

0353-9466

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost